Inozyme Pharma Reports Full Year 2020 Financial Results and Provides Business Highlights by Carolyn Helms | Mar 25, 2021 | Portfolio News
WEP Clinical Expands Availability Of Xenleta® (Lefamulin) Named Patient Program In Partnership With Nabriva Therapeutics by Carolyn Helms | Mar 24, 2021 | Portfolio News
Aptinyx Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update by Carolyn Helms | Mar 24, 2021 | Portfolio News
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board by Carolyn Helms | Mar 23, 2021 | Portfolio News
89bio Presents Additional Analysis of Phase 1b/2a NASH Study at the Annual ENDO 2021 Conference by Carolyn Helms | Mar 20, 2021 | Portfolio News
